Lim S, Sohn M, Shin Y, Ferrannini E, et al. Initial combination of metformin, sitagliptin, and empagliflozin in drug-naive patients with type 2 diabetes: Safety and metabolic effects. Diabetes Obes Metab 2021 Dec 14. doi: 10.1111/dom.14627.
PMID: 34908220